Dr. Mark Posnick, DO

NPI: 1194218834
Total Payments
$2,770
2024 Payments
$432.64
Companies
15
Transactions
35
Medicare Patients
492
Medicare Billing
$56,288

Payment Breakdown by Category

Food & Beverage$2,770 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,770 35 100.0%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $598.92 6 $0 (2024)
ABBVIE INC. $596.59 8 $0 (2024)
Novartis Pharmaceuticals Corporation $237.35 2 $0 (2023)
UCB, Inc. $217.58 2 $0 (2023)
Lilly USA, LLC $175.78 3 $0 (2024)
SANOFI-AVENTIS U.S. LLC $168.58 2 $0 (2021)
Incyte Corporation $138.61 2 $0 (2023)
E.R. Squibb & Sons, L.L.C. $133.54 2 $0 (2022)
Amgen Inc. $114.22 1 $0 (2022)
Sun Pharmaceutical Industries Inc. $98.81 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $432.64 5 ABBVIE INC. ($162.91)
2023 $441.59 5 Novartis Pharmaceuticals Corporation ($115.14)
2022 $1,128 13 GENZYME CORPORATION ($224.11)
2021 $557.26 7 GENZYME CORPORATION ($186.41)
2020 $15.64 1 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($15.64)
2019 $195.03 4 PFIZER INC. ($92.64)

All Payment Transactions

35 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/05/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $102.10 General
Category: Immunology
10/23/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $85.74 General
09/27/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $55.41 General
Category: IMMUNOLOGY
09/03/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $107.50 General
Category: IMMUNOLOGY
06/04/2024 Lilly USA, LLC OLUMIANT (Drug) Food and Beverage In-kind items and services $81.89 General
Category: Immunology
12/01/2023 Novartis Pharmaceuticals Corporation COSENTYX (Drug) Food and Beverage In-kind items and services $115.14 General
Category: Dermatology
11/14/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $69.00 General
Category: IMMUNOLOGY
10/23/2023 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $112.33 General
Category: Immunology
05/26/2023 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $58.82 General
Category: Dermatology
02/15/2023 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $86.30 General
Category: Immunology
11/17/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $85.19 General
Category: IMMUNOLOGY
10/13/2022 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $114.22 General
Category: Inflammation
09/13/2022 Incyte Corporation Food and Beverage Cash or cash equivalent $79.79 General
08/25/2022 Janssen Scientific Affairs, LLC Food and Beverage In-kind items and services $71.12 General
08/04/2022 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $85.09 General
06/14/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $61.70 General
Category: IMMUNOLOGY
06/09/2022 Lilly USA, LLC Food and Beverage In-kind items and services $78.92 General
05/05/2022 GENZYME CORPORATION Food and Beverage In-kind items and services $124.98 General
04/05/2022 Sun Pharmaceutical Industries Inc. Winlevi (Drug), ILUMYA Food and Beverage Cash or cash equivalent $98.81 General
Category: Dermatology
03/27/2022 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $48.45 General
03/03/2022 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $99.13 General
Category: Immunology
02/24/2022 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $105.25 General
Category: Immunology
01/27/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $75.14 General
Category: IMMUNOLOGY
12/01/2021 SANOFI-AVENTIS U.S. LLC DUPIXENT (Biological), DUPIXENT Food and Beverage In-kind items and services $91.02 General
Category: Immunology
11/19/2021 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Food and Beverage In-kind items and services $122.21 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 328 425 $98,275 $34,228
2022 3 120 197 $53,982 $17,094
2021 2 44 56 $13,573 $4,967
Total Patients
492
Total Services
678
Medicare Billing
$56,288
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 80 164 $50,020 $14,452 28.9%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 63 63 $8,757 $4,776 54.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 31 31 $8,494 $4,008 47.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 38 51 $10,965 $3,149 28.7%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 11 11 $6,137 $3,078 50.2%
G0008 Administration of influenza virus vaccine Office 2023 73 73 $4,088 $2,256 55.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 21 21 $9,198 $2,169 23.6%
G0009 Administration of pneumococcal vaccine Office 2023 11 11 $616.00 $340.01 55.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 60 124 $37,520 $11,192 29.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 47 60 $12,900 $4,180 32.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 13 13 $3,562 $1,721 48.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 26 35 $9,625 $3,503 36.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 18 21 $3,948 $1,464 37.1%

About Dr. Mark Posnick, DO

Dr. Mark Posnick, DO is a Family Medicine healthcare provider based in Nashua, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2018. The National Provider Identifier (NPI) number assigned to this provider is 1194218834.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Posnick, DO has received a total of $2,770 in payments from pharmaceutical and medical device companies, with $432.64 received in 2024. These payments were reported across 35 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,770).

As a Medicare-enrolled provider, Posnick has provided services to 492 Medicare beneficiaries, totaling 678 services with total Medicare billing of $56,288. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Family Medicine
  • Location Nashua, NH
  • Active Since 06/07/2018
  • Last Updated 01/14/2022
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1194218834

Products in Payments

  • DUPIXENT (Biological) $490.75
  • SKYRIZI (Biological) $465.89
  • RINVOQ (Biological) $130.70
  • COSENTYX (Biological) $122.21
  • COSENTYX (Drug) $115.14
  • Otezla (Drug) $114.22
  • Bimzelx (Biological) $112.33
  • Cimzia (Drug) $105.25
  • Winlevi (Drug) $98.81
  • EUCRISA (Drug) $92.64
  • OLUMIANT (Drug) $81.89
  • DUPIXENT (Drug) $77.56
  • OPZELURA (Drug) $58.82
  • LifeVest (Device) $25.34
  • BEXSERO (Biological) $15.13
  • EMGALITY (Drug) $14.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Nashua